Literature DB >> 7665656

Isolation and characterization of a naturally occurring parainfluenza 3 virus variant.

E M Swierkosz1, D D Erdman, T Bonnot, C Schneiderheinze, J L Waner.   

Abstract

A parainfluenza 3 virus variant which failed to react with parainfluenza 3 virus-specific monoclonal anti-bodies from two commercial sources was isolated from a 14-month-old boy. Analysis of the coding region of the hemagglutinin-neuraminidase gene identified 36 nucleotide changes and 4 amino acid changes compared with a consensus sequence derived from strains isolated from 1957 through 1983. Two unique amino acid changes occurred at positions 174 and 283, which are close to identified epitopes in the hemagglutinin-neuraminidase protein. Ongoing viral surveillance to detect variants is important, particularly in regard to vaccine development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665656      PMCID: PMC228281          DOI: 10.1128/jcm.33.7.1839-1841.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  The complete nucleotide sequence of the JS strain of human parainfluenza virus type 3: comparison with the Wash/47885/57 prototype strain.

Authors:  A Stokes; E L Tierney; B R Murphy; S L Hall
Journal:  Virus Res       Date:  1992-09-01       Impact factor: 3.303

2.  Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus 3 hemagglutinin-neuraminidase gene: comparison with other paramyxoviruses.

Authors:  D G Storey; M J Côté; K Dimock; C Y Kang
Journal:  Intervirology       Date:  1987       Impact factor: 1.763

3.  Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.

Authors:  K L van Wyke Coelingh; C C Winter; E D Jorgensen; B R Murphy
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983.

Authors:  K L van Wyke Coelingh; C C Winter; B R Murphy
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

5.  Evaluation of two immunofluorescence assays with monoclonal antibodies for typing of herpes simplex virus.

Authors:  E M Swierkosz; M Q Arens; R R Schmidt; T Armstrong
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

6.  Production of monoclonal antibodies against parainfluenza 3 virus and their use in diagnosis by immunofluorescence.

Authors:  J L Waner; N J Whitehurst; T Downs; D G Graves
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

7.  Comparison of monoclonal antibody time-resolved fluoroimmunoassay with monoclonal antibody capture-biotinylated detector enzyme immunoassay for respiratory syncytial virus and parainfluenza virus antigen detection.

Authors:  J C Hierholzer; P G Bingham; R A Coombs; K H Johansson; L J Anderson; P E Halonen
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

8.  Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics.

Authors:  A M Knott; C E Long; C B Hall
Journal:  Pediatr Infect Dis J       Date:  1994-04       Impact factor: 2.129

9.  Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children.

Authors:  R B Belshe; R A Karron; F K Newman; E L Anderson; S L Nugent; M Steinhoff; M L Clements; M H Wilson; S L Hall; E L Tierney
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Polymer support oligonucleotide synthesis XVIII: use of beta-cyanoethyl-N,N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product.

Authors:  N D Sinha; J Biernat; J McManus; H Köster
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

View more
  7 in total

1.  Two distinct human parainfluenza virus type 1 genotypes detected during the 1991 Milwaukee epidemic.

Authors:  K J Henrickson; L L Savatski
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

2.  Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCR.

Authors:  J E Echevarría; D D Erdman; E M Swierkosz; B P Holloway; L J Anderson
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  Complete genome sequence and pathogenicity of two swine parainfluenzavirus 3 isolates from pigs in the United States.

Authors:  Dan Qiao; Bruce H Janke; Subbiah Elankumaran
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

4.  Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4.

Authors:  Kate E Templeton; Sitha A Scheltinga; Matthias F C Beersma; Aloys C M Kroes; Eric C J Claas
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  A sensitive, specific, and cost-effective multiplex reverse transcriptase-PCR assay for the detection of seven common respiratory viruses in respiratory samples.

Authors:  Melanie W Syrmis; David M Whiley; Marion Thomas; Ian M Mackay; Jeanette Williamson; David J Siebert; Michael D Nissen; Theo P Sloots
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

6.  Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay.

Authors:  C Osiowy
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

7.  The common cold: a review of the literature.

Authors:  Dennis Wat
Journal:  Eur J Intern Med       Date:  2004-04       Impact factor: 4.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.